This protocol covers Yersiniosis in patients who develop skin lesions as part of their presentation. The decision to treat — and how — depends on the severity of cutaneous involvement.
Mild skin lesions associated with Yersiniosis do not usually require specific therapy. When lesions are severe, however, systemic treatment becomes necessary, and a defined agent-based approach applies.
For severe skin lesions, the protocol calls for systemic agents from distinct drug classes. The full selection criteria, agent-specific guidance, and clinical algorithm are available in the complete protocol below.
DOI: 10.3390/microorganisms13051133